Cambridge Cog Share News (COG)

Cambridge Cog Information

Buy COG Shares
Add COG to Watchlist
Add COG to Alert

Share Price Information for Cambridge Cog (COG)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 51.50

Bid: 51.00

Ask: 52.00

Change: 0.00 (0.00%)

Spread: 1.00 (1.961%)

Open: 51.50

High: 51.50

Low: 51.50

Prev. Close: 51.50

Last checked at -

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Mon, 14th Sep 2020 13:13

Cambridge Cognition Holdings PLC - Cambridge, England-based neuroscience technology - Appoints Diurnal Group PLC Chief Financial Officer Richard Bungay as non-executive director, effective immediately. Bungay joined Diurnal at the start of 2017, moving from Mereo BioPharma Group PLC, where he had been CFO and chief operation officer. Previously, he had been CFO of Verona Pharma PLC.

Current stock price: 40.10 pence

Year-to-date change: up 43%

By Tom Waite; thomaslwaite@alliancenews.com

More News

30 Mar 2021 16:03

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

30 Mar 2021 13:56

Cambridge Cognition wins fourth schizophrenia trial contract

(Sharecast News) - Cambridge Cognition has won a £1.3m contract as the cognitive assessment partner for a schizophrenia trial, it announced on Tuesday.

23 Mar 2021 11:58

Cambridge Cognition shares surge as it eyes profitability in 2021

16 Mar 2021 15:53

UK earnings, trading statements calendar - next 7 days

19 Jan 2021 13:45

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

21 Dec 2020 14:20

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

22 Sep 2020 14:12

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

15 Sep 2020 15:53

UK Earnings, Trading Statements Calendar - Next 7 Days

1 Sep 2020 16:22

Cambridge Cognition wins £2m contract with pharma firm

(Sharecast News) - Brain health company Cambridge Cognition has won a £2m contract as the cognitive assessment partner for three late-phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia, it announced on Tuesday.

1 Sep 2020 11:57

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

27 Jul 2020 17:58

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

20 Jul 2020 15:53

UK Shareholder Meetings Calendar - Next 7 Days

15 Jul 2020 16:20

Cambridge Cognition joins Covid healthcare worker investigation

(Sharecast News) - Cambridge Cognition is collaborating with 4YouandMe and the Center for International Emergency Medical Services (CIEMS), it announced on Wednesday, to investigate the use of wearables and mobile phones to measure stress recovery in front line healthcare workers caring for Covid-19 positive patients in the United States.

Latest Share Chat

Cambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Login to your account

Quickpicks are a member only feature

Login to your account